PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 142 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $826,000 | -65.0% | 64,993 | +6.7% | 0.05% | -66.7% |
| Q1 2019 | $2,362,000 | +101.9% | 60,893 | +5.9% | 0.14% | +88.0% |
| Q4 2018 | $1,170,000 | -19.5% | 57,493 | +133.8% | 0.08% | +27.1% |
| Q2 2018 | $1,454,000 | -48.4% | 24,593 | -40.6% | 0.06% | -47.8% |
| Q1 2018 | $2,816,000 | -15.2% | 41,393 | +23.2% | 0.11% | -23.1% |
| Q4 2017 | $3,320,000 | +116.0% | 33,590 | +90.9% | 0.15% | +81.5% |
| Q2 2017 | $1,537,000 | +97.3% | 17,594 | -30.7% | 0.08% | +76.1% |
| Q4 2016 | $779,000 | -10.6% | 25,400 | +95.4% | 0.05% | -83.7% |
| Q3 2016 | $871,000 | -25.8% | 13,000 | +14.6% | 0.28% | +354.8% |
| Q4 2013 | $1,174,000 | -18.6% | 11,340 | -57.8% | 0.06% | -21.5% |
| Q3 2013 | $1,442,000 | +61.1% | 26,880 | +33.3% | 0.08% | +172.4% |
| Q2 2013 | $895,000 | – | 20,172 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |